-
1
المؤلفون: Shuai Tuo, Yang Yang, Hong-Li Zhu, Song-wei Li, Rui-li Yu, Feng Zhang, Xue-Chun Lu, Hai-Tao Wang, Xiao‐Xiong Wu, Xuanchi Wang, Bo Yang, Xiao-Hua Chi, Li-Li Cai
المصدر: Clinical Therapeutics. 36:1104-1111
مصطلحات موضوعية: Male, Oncology, Antimetabolites, Antineoplastic, medicine.medical_specialty, Ultra low dose, Combination therapy, medicine.medical_treatment, Decitabine, Transplantation, Autologous, Cytokine-Induced Killer Cells, Internal medicine, Biomarkers, Tumor, medicine, Humans, Pharmacology (medical), Aged, 80 and over, Pharmacology, Chemotherapy, Cytokine-induced killer cell, business.industry, Myeloid leukemia, Combined Modality Therapy, Autologous Cytokine-induced Killer Cells, Leukemia, Myeloid, Acute, Treatment Outcome, Myelodysplastic Syndromes, Immunology, Azacitidine, Myelocytic leukemia, business, medicine.drug